0QF:ETR
Moderna Inc
€171.66
arrow_upward
+0.47%(+0.80) 1D
Oct 7, 5:35:36 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0QF...
Open
€165.00
High
€172.54
Low
€163.14
Mkt. cap
76.26B
Avg. vol.
29.38K
Volume
32.49K
52-wk high
€188.30
52-wk low
€19.37
No. of employees
5K
Open
€165.00
High
€172.54
Low
€163.14
Mkt. cap
76.26B
Avg. vol.
29.38K
Volume
32.49K
52-wk high
€188.30
52-wk low
€19.37
No. of employees
5K
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
Moderna stock gains 1.08 percent as targets lag price
Traders Union
·
2 hours ago
Moderna stock resistance test at $197.74: Key levels to watch
Investing.com UK
·
4 hours ago
Tempus expands collaboration with Merck and Moderna on therapy By Investing.com
Yahoo Finance
·
6 hours ago
Novavax and Moderna Shares Fall as Citi Assesses Vaccine Sector Volatility
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc